Exendin-4 Ameliorates Traumatic Brain Injury-Induced Cognitive Impairment in Rats
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Traumatic brain injury represents a major public health issue that affects 1.7 million Americans each year and is a primary contributing factor (30.5%) of all injury-related deaths in the United States. The occurrence of traumatic brain injury is likely underestimated and thus has been termed "a silent epidemic". Exendin-4 is a long-acting glucagon-like peptide-1 receptor agonist approved for the treatment of type 2 diabetes mellitus that not only effectively induces glucose-dependent insulin secretion to regulate blood glucose levels but also reduces apoptotic cell death of pancreatic β-cells. Accumulating evidence also supports a neurotrophic and neuroprotective role of glucagon-like peptide-1 in an array of cellular and animal neurodegeneration models. In this study, we evaluated the neuroprotective effects of Exendin-4 using a glutamate toxicity model in vitro and fluid percussion injury in vivo. We found neuroprotective effects of Exendin-4 both in vitro, using markers of cell death, and in vivo, using markers of cognitive function, as assessed by Morris Water Maze. In combination with the reported benefits of ex-4 in other TBI models, these data support repositioning of Exendin-4 as a potential treatment for traumatic brain injury.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Biology of Incretins: GLP-1 and GIP
Baggio, L. L., & Drucker, D. J. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.054 · Cited by 3,639
Pharmacology, physiology, and mechanisms of incretin hormone action.
Campbell, J. E., & Drucker, D. J. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.04.008 · Cited by 1,500
Drucker, D. J., Buse, J. B., Taylor, K., Kendall, D. M., Trautmann, M., Zhuang, D., & Porter, L. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61206-4 · Cited by 1,070
Li, Y., Perry, T., Kindy, M. S., Harvey, B. K., Tweedie, D., Holloway, H. W., Powers, K., Shen, H., Egan, J. M., Sambamurti, K., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0806720106 · Cited by 589 · cited 3×
“The presence of the GLP-1R was verified, in accord with prior studies [21,36], on both SHSY5Y human neuroblastoma cells and rat primary neurons by RT-RCR; GLP-1R mRNA possessed the expected RT–PCR product size of 190 bp.”
BackgroundMethodResultSelf-citationGöke, R., Larsen, P. J., Mikkelsen, J. D., & Sheikh, S. P. (1995) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1995.tb00650.x · Cited by 474
Protection and Reversal of Excitotoxic Neuronal Damage by Glucagon-Like Peptide-1 and Exendin-4
Perry, T., Haughey, N. J., Mattson, M. P., Egan, J. M., & Greig, N. H. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.037481 · Cited by 380 · cited 3×
“To obtain rat primary neurons, the hippocampal area was obtained from day 18 Sprague-Dawley rats and subjected to mild trypsinization [25].”
BackgroundMethodResultSelf-citationProduction of cytokines following brain injury: Beneficial and deleterious for the damaged tissue
Morganti-Kossman, M. C., Lenzlinger, P. M., Hans, V, Stahel, P., Csuka, E., Ammann, E., Stocker, R., Trentz, O., & Kossmann, T. (1997) · Molecular Psychiatry · doi:10.1038/sj.mp.4000227 · Cited by 267
Washington, P. M., Forcelli, P. A., Wilkins, T., Zapple, D. N., Parsadanian, M., & Burns, M. P. (2012) · Journal of Neurotrauma · doi:10.1089/neu.2012.2456 · Cited by 228
Glucagon-like Peptide–1 Analogues for Type 2 Diabetes Mellitus: Current and Emerging Agents
Gallwitz, B. (2011) · Drugs · doi:10.2165/11592810-000000000-00000 · Cited by 142
Hinzman, J. M., Thomas, T. C., Burmeister, J. J., Quintero, J. E., Huettl, P., Pomerleau, F., Gerhardt, G. A., & Lifshitz, J. (2010) · Journal of Neurotrauma · doi:10.1089/neu.2009.1238 · Cited by 140 · cited 1×
“Glutamate toxicity is implicated as a key mechanism underlying neuronal dysfunction and death following TBI [32,33].”
Background
Cited by
Athauda, D., & Foltynie, T. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2016.01.013 · Cited by 383
“60 Eakin, K. et al. (2013) Exendin-4 ameliorates traumatic brain injury-induced cognitive impairment in rats. PLOS ONE 8, e82016 61 Greig, N.H. et al. (2014) Incretin mimetics as pharmacologic tools to elucidate”
BackgroundAstrocytes as Key Regulators of Brain Energy Metabolism: New Therapeutic Perspectives
Beard, E., Lengacher, S., Dias, S., Magistretti, P. J., & Finsterwald, C. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2021.825816 · Cited by 302
Kopp, K. O., Glotfelty, E. J., Li, Y., & Greig, N. H. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106550 · Cited by 298
Self-citationSalameh, T. S., Rhea, E. M., Talbot, K., & Banks, W. A. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.114187 · Cited by 188
“Promoting neuroprotection in many, not necessarily mutually exclusive, ways, specifically by enhancing DNA repair [151]; increasing expression and signaling of brain-derived neurotrophic factor (BDNF) [55, 152, 153]; reducing Aβ oligomers [38], Aβ plaque load [38-40, 154-157], Aβ toxicity [158-162], advanced glycation…”
BackgroundBrain insulin resistance: role in neurodegenerative disease and potential for targeting
Hölscher, C. (2020) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2020.1738383 · Cited by 180
Metadata
- Authors
- Eakin, K., Li, Y., Chiang, Y.-H., Hoffer, B. J., Rosenheim, H., Greig, N. H., & Miller, J. P.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-12-02
- Volume
- 8
- Issue
- 12
- Pages
- e82016
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W1979823837
- Cited by
- 67
- References
- 11
- FWCI
- 3.99
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Exendin-4 Ameliorates Traumatic Brain Injury-Induced Cognitive Impairment in Rats. https://app.cochat.ai/papers/10.1371/journal.pone.0082016
- The paper
- Eakin, K., Li, Y., Chiang, Y.-H., Hoffer, B. J., Rosenheim, H., Greig, N. H., & Miller, J. P. (2013). Exendin-4 Ameliorates Traumatic Brain Injury-Induced Cognitive Impairment in Rats. PLoS ONE. https://doi.org/10.1371/journal.pone.0082016
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.